Mirabegron

Overview

Mirabegron is a beta-3 adrenergic agonist used for the treatment of overactive bladder. It works by relaxing the detrusor muscle in the bladder, increasing its storage capacity.

API suppliers (3)

Suppliers of Mirabegron backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Zhejiang Huahai Pharmaceutical Co., Ltd.China2 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (16 approved US products), the latest listed US patent on Mirabegron expires 29 Sept 2036. Generic API sourcing typically opens up once these lapse.

Therapeutic areas